We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
CONMED
CNMD
$1.48B
| $355K | ﹤0.01% |
3,708
+472
| +15% | +$56.6K |
|
1802
Enanta Pharmaceuticals
ENTA
$402M
| $354K | ﹤0.01% |
7,490
-503
| -6% | -$27.3K |
|
1803
Viking Therapeutics
VKTX
$4.02B
| $354K | ﹤0.01% |
122,356
+78,431
| +179% | +$194K |
|
|
AZPN
1804
DELISTED
Aspen Technology Inc
AZPN
| $353K | ﹤0.01% |
+1,924
| New | +$342K |
|
1805
Floor & Decor
FND
$6.3B
| $351K | ﹤0.01% |
5,702
-18,754
| -77% | -$1.41M |
|
1806
Monarch Casino & Resort
MCRI
$2.17B
| $351K | ﹤0.01% |
5,986
+2,624
| +78% | +$184K |
|
1807
Green Plains
GPRE
$1.06B
| $349K | ﹤0.01% |
12,853
+683
| +6% | +$21.4K |
|
1808
Aaon
AAON
$7.31B
| $348K | ﹤0.01% |
9,524
-2,382
| -20% | -$83.4K |
|
1809
EverQuote
EVER
$900M
| $347K | ﹤0.01% |
39,287
+4,106
| +12% | +$46.9K |
|
1810
Huntington Bancshares
HBAN
$35.6B
| $347K | ﹤0.01% |
29,370
-53,818
| -65% | -$714K |
|
1811
Helios Technologies
HLIO
$2.69B
| $347K | ﹤0.01% |
5,233
-852
| -14% | -$59.1K |
|
|
GLDD
1812
DELISTED
Great Lakes Dredge & Dock
GLDD
| $344K | ﹤0.01% |
26,224
-6,901
| -21% | -$97.9K |
|
|
CDMO
1813
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $344K | ﹤0.01% |
22,538
-3,495
| -13% | -$51.7K |
|
1814
V2X
VVX
$2.6B
| $342K | ﹤0.01% |
10,213
-13,201
| -56% | -$467K |
|
|
TCS
1815
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $341K | ﹤0.01% |
3,651
+810
| +29% | +$91.9K |
|
1816
Columbia Financial
CLBK
$1.12B
| $340K | ﹤0.01% |
15,592
+5,786
| +59% | +$121K |
|
1817
PRA Group
PRAA
$723M
| $339K | ﹤0.01% |
9,336
-8,361
| -47% | -$331K |
|
1818
Health Catalyst
HCAT
$127M
| $338K | ﹤0.01% |
+23,341
| New | +$398K |
|
1819
Heritage Insurance Holdings
HRTG
$990M
| $338K | ﹤0.01% |
127,969
-10,388
| -8% | -$44.3K |
|
|
FREE
1820
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $337K | ﹤0.01% |
+54,299
| New | +$370K |
|
|
RAD
1821
DELISTED
Rite Aid Corporation
RAD
| $337K | ﹤0.01% |
49,995
-20,960
| -30% | -$139K |
|
|
YELL
1822
DELISTED
Yellow Corporation Common Stock
YELL
| $337K | ﹤0.01% |
115,040
+9,703
| +9% | +$39.4K |
|
|
HTO
1823
H2O America
HTO
$2.56B
| $336K | ﹤0.01% |
5,380
+15
| +0.3% | +$928 |
|
1824
SSR Mining
SSRM
$6.4B
| $336K | ﹤0.01% |
+20,127
| New | +$415K |
|
1825
Sunstone Hotel Investors
SHO
$2.01B
| $335K | ﹤0.01% |
33,780
-7,207
| -18% | -$82.4K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.